Dr. Reddy's (DRREDDY) | Stock Overview & Key Data
Dr. Reddy's Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹1,421.49 on August 19, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dr. Reddy's
DRREDDY
|
1.10T Large-cap | 0.31% | -4.28% | 0.20% | -0.09% | 2.08% | -6.39% | 29.74% | 20.69% | 112.36% | 310.53% | 902.28% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | 0.96% | -3.84% | 1.28% | 0.50% | 4.93% | 7.10% | 82.23% | 170.41% | 143.23% | 656.74% | 2,541.29% |
|
Divi's Laboratories
DIVISLAB
|
1.69T Large-cap | 1.34% | -2.25% | 8.85% | 4.11% | 4.17% | -0.43% | 85.44% | 58.15% | 496.33% | 1,610.60% | 10,946.76% |
|
Torrent
TORNTPHARM
|
1.39T Large-cap | 2.12% | 2.23% | 5.56% | 19.07% | 17.04% | 40.54% | 146.00% | 215.51% | 578.42% | 2,737.14% | 10,046.95% |
|
Lupin
LUPIN
|
1.07T Large-cap | 0.83% | -0.14% | -0.76% | 8.63% | 8.10% | 14.69% | 176.15% | 98.45% | 56.65% | 418.49% | 2,332.69% |
|
Cipla
CIPLA
|
1.06T Large-cap | -0.42% | -3.49% | 6.32% | -8.35% | -7.92% | -7.69% | 38.10% | 44.59% | 185.62% | 323.08% | 558.95% |
Ownership & Short Interest
Calculate Your Dr. Reddy's Investment Returns
Long-Term Investment Performance Analysis
Dr. Reddy's stock price in Jul 2016 was ₹719.97, A ₹1,000.00 lump sum investment in Dr. Reddy's made 9 years ago would be worth approximately ₹1,777.16 today, representing a solid return of 77.72%. This translates to an annualized return (CAGR) of 5.98%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is DRREDDY's 52-week high and low?
- In the last 52 weeks, Dr. Reddy's reached a high of ₹1,375.90 (on April 29, 2026) and a low of ₹1,148.40 (on January 21, 2026).
- What is the market cap and P/E ratio for DRREDDY?
- Curious about Dr. Reddy's's size and valuation? Its market capitalization stands at 1.10T. When it comes to valuation, the P/E ratio (trailing twelve months) is 19.40, and the forward P/E (looking ahead) is 24.12.
- Does DRREDDY pay dividends? If so, what's the yield?
- Yes, Dr. Reddy's is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 11.59%, and the company has paid an average of ₹49.30 per share annually over the past 3 years.
- Who are Dr. Reddy's's main competitors or similar companies to consider before investing?
When looking at Dr. Reddy's, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.10% 82.23% Divi's Laboratories
DIVISLAB1.69T Healthcare Drug Manufacturers - Specialty & Generic -0.43% 85.44% Torrent
TORNTPHARM1.39T Healthcare Drug Manufacturers - Specialty & Generic 40.54% 146.00% Lupin
LUPIN1.07T Healthcare Drug Manufacturers - Specialty & Generic 14.69% 176.15% Cipla
CIPLA1.06T Healthcare Drug Manufacturers - Specialty & Generic -7.69% 38.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dr. Reddy's Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Dr. Reddy's's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.10%, the Debt to Equity ratio from the most recent quarter is 18.03, and its Gross Profit Margin stands at 53.63%.
- What is the recent revenue and earnings growth for DRREDDY?
- Looking at Dr. Reddy's's growth, its revenue over the trailing twelve months (TTM) was INR346B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.40%, and quarterly earnings saw a YoY growth of -14.40%.
- How much of DRREDDY stock is held by insiders and institutions?
- Wondering who owns Dr. Reddy's stock? Company insiders (like executives and directors) hold about 29.45% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 51.84%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.